Skip to main content

Table 1 Percentage of change from baseline reaction latency of BALB/c mice at 1 hour post-drug treatment in the hot plate test.

From: Enhancement of antinociception by coadminstration of minocycline and a non-steroidal anti-inflammatory drug indomethacin in naïve mice and murine models of LPS-induced thermal hyperalgesia and monoarthritis

Drug and dose administered to mice

% Change in reaction latency (mean ± S.E.M of the values obtained from 6 to 16 animals.)#

Statistical significance§

Vehicle for indomethacin

-4.64 ± 4.619 (n = 7)

 

Indomethacin 5 mg/kg

-10.43 ± 4.11 (n = 7)

ns

Indomethacin 10 mg/kg

-1.02 ± 3.85 (n = 7)

ns

Indomethacin 20 mg/kg

-6.43 ± 5.75 (n = 7)

ns

Indomethacin 50 mg/kg

2.03 ± 10.29 (n = 7)

ns

Vehicle for minocycline

-5.34 ± 2.68 (n = 16)

 

Minocycline 12.5 mg/kg

-6.78 ± 3.09 (n = 11)

ns

Minocycline 25 mg/kg

-21.63 ± 2.24 (n = 11)

**

Minocycline 50 mg/kg

-34.16 ± 4.31 (n = 10)

**

Minocycline 100 mg/kg

-34.21 ± 4.08 (n = 8)

**

Vehicles for indomethacin and minocycline

-4.97 ± 2.51 (n = 16)

 

Indomethacin 5 + minocycline 50 mg/kg

21.49 ± 4.70 (n = 6)

**

Indomethacin 10 + minocycline 50 mg/kg

24.567 ± 4.05 (n = 16)

**

Indomethacin 10 + minocycline 25 mg/kg

-7.65 ± 4.97 (n = 6)

ns

  1. # (response latency after drug treatment - baseline latency)/baseline latency × 100.
  2. §Statistically significant differences in comparison with drug vehicle: ** p < 0.01; ns: no statically significant differences in comparison with drug vehicle (one-way ANOVA followed by Newman-Keuls test).